pyrazines has been researched along with Purpura, Thrombotic Thrombocytopenic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, HI; Park, SJ; Shin, JI | 1 |
| de Jong, H; Schreuder, MF; van Balen, T; van de Kar, NC | 1 |
| De Maeyer, N; Delforge, M; Dierickx, D; Meersseman, W; Wauters, J | 1 |
| Ma, A; Mazepa, MA; Moll, S; Park, YA; Raval, JS | 1 |
| Matevosyan, K; Rutherford, C; Sarode, R; Shen, YM; Yates, S | 1 |
| Moore, H; Romeril, K | 1 |
| Mehta, N; Niesvizky, R; Saxena, A | 1 |
| Oh, DH; Opat, SS; Shortt, J | 1 |
2 review(s) available for pyrazines and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Hyperammonemia, resolved by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Coma; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Humans; Hyperammonemia; Paraproteinemias; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Respiration, Artificial | 2014 |
Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.
Topics: ADAM Proteins; ADAMTS13 Protein; Boronic Acids; Bortezomib; Female; Fever of Unknown Origin; Humans; Middle Aged; Multiple Myeloma; Purpura, Thrombotic Thrombocytopenic; Pyrazines | 2011 |
6 other study(ies) available for pyrazines and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Antibody depletion by bortezomib through blocking of antigen presentation.
Topics: ADAM Proteins; Autoantibodies; B-Lymphocytes; Boronic Acids; Female; Humans; Plasma Cells; Protease Inhibitors; Purpura, Thrombotic Thrombocytopenic; Pyrazines | 2013 |
Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Antibodies, Monoclonal; Boronic Acids; Bortezomib; Female; Humans; Immunosuppressive Agents; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Recurrence; Remission Induction; Treatment Outcome | 2014 |
Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Antineoplastic Agents; Autoantibodies; Boronic Acids; Bortezomib; Female; Humans; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Recurrence; Remission Induction | 2014 |
Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Cyclophosphamide; Drug Resistance; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Recurrence; Remission Induction; Rituximab; Staphylococcal Infections | 2014 |
Bortezomib-induced thrombotic thrombocytopaenic purpura.
Topics: Aged; Anemia, Hemolytic; Antineoplastic Agents; Boronic Acids; Bortezomib; Confusion; Female; Humans; Multiple Myeloma; Plasma Exchange; Plasmapheresis; Platelet Count; Prognosis; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Severity of Illness Index; Treatment Outcome | 2012 |
ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Autoantibodies; B-Lymphocytes; Boronic Acids; Bortezomib; Female; Humans; Immunosuppressive Agents; Middle Aged; Plasma Cells; Protease Inhibitors; Purpura, Thrombotic Thrombocytopenic; Pyrazines | 2013 |